Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.

Highest usefulness score first. Studies without a score come last.

  1. Hippocampal morphometry in schizophrenia by high dimensional brain mapping

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Proceedings of the National Academy of Sciences of the United States of America 1998-09-01 Hippocampus size on brain scans

    Theories of the pathophysiology of schizophrenia have implicated the hippocampus, but controversy remains regarding hippocampal abnormalities in patients with schizophrenia.

  2. Cytokine actions in the central nervous system

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Cytokine & growth factor reviews 1998-09-01 Vascular contributions

    Cytokines and chemokines have been implicated in contributing to the initiation, propagation and regulation of immune and inflammatory responses.

  3. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ("pallido-ponto-nigral degeneration")

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neuropathology and experimental neurology 1998-06-01 Disease mechanisms

    A group of similar autosomal dominant hereditary neurodegenerative disorders have been linked to chromosome 17 in thirteen kindreds.

  4. Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of neuroscience : the official journal of the Society for Neuroscience 1998-04-01 Risk genes beyond APOE

    In an attempt to elucidate the pathological implications of intracellular accumulation of the amyloid precursor protein (APP) in postmitotic neurons in vivo, we transferred APP695 cDNA into rat hippocampal neurons by using a replication-defective adenovirus vector.

    Why it matters

    In rats, overexpressing wild-type amyloid precursor protein in hippocampal neurons caused degeneration of some of those neurons. This is animal work on the effects of amyloid precursor protein accumulation and does not test any treatment, cure, or prevention.

  5. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Brain pathology (Zurich, Switzerland) 1998-04-01 Disease mechanisms

    Frontotemporal dementia is a neurological disorder characterised by personality changes, deterioration of memory and executive functions as well as stereotypical behaviour.

  6. Nitric oxide in neurodegeneration

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Progress in brain research 1998-01-01 Vascular contributions

    Nitric oxide (NO) is a unique biological messenger molecule which mediates diverse physiologic roles.

  7. Familial multiple system tauopathy with presenile dementia: a disease with abundant neuronal and glial tau filaments

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Proceedings of the National Academy of Sciences of the United States of America 1997-04-01 Disease mechanisms

    Neurofibrillary lesions made of hyperphosphorylated microtubule-associated protein tau constitute not only one of the defining neuropathological features of Alzheimer disease but also are present in a number of other neurodegenerative diseases with dementia.

  8. Chronic alcohol consumption does not cause hippocampal neuron loss in humans

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Hippocampus 1997-01-01 Hippocampus size on brain scans

    High alcohol consumption for long periods of time causes significant hippocampal neurodegeneration in rodents.

  9. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The American journal of psychiatry 1996-12-01 Hippocampus size on brain scans

    NAA-relative signal intensity reductions in schizophrenia appear to be remarkably localized, involving primarily the hippocampal region and the dorsolateral prefrontal cortex, two regions implicated prominently in the pathophysiology of this disorder.

  10. Differential susceptibility to neurofibrillary pathology among patients with Down syndrome

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Dementia (Basel, Switzerland) 1996-05-01 Down syndrome and Alzheimer's

    Individual differences in the development of neurofibrillary changes were examined in eight cortical regions in the brains of 43 subjects with Down syndrome (DS; age range, 15-69 years) using sections stained with monoclonal antibodies (mAb) tau-1 and 3-39.

    Why it matters

    Among 43 people with Down syndrome, neurofibrillary pathology was found in all 20 cases above 36 years of age, with wide variation in severity between individuals. The authors suggest this indicates differing susceptibility to Alzheimer-type changes, but no treatment, cure, or prevention was tested.

  11. Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Dementia (Basel, Switzerland) 1996-05-01 Disease mechanisms

    The most important new development during recent years in the field of degenerative dementia concerns synaptic pathology.

  12. Possible roles of the complement (C) system in the normal and injured brain were explored with inbred mice that carried a frameshift mutation in the C5 gene.

    Why it matters

    In mice with a C5 gene mutation, kainic acid caused more hippocampal neuron death and greater astrocyte mRNA induction than in C5-sufficient mice, and astrocyte cultures produced more IL-6 and TNF after an inflammatory stimulus. These are animal and cell-culture findings about complement C5 and neurodegeneration, not a treatment or prevention for Alzheimer's disease.

  13. Anterior hippocampal volume reductions predict frontal lobe dysfunction in first episode schizophrenia

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Schizophrenia research 1995-09-01 Hippocampus size on brain scans

    This study examined relations of mesiotemporal lobe tissue volumes with neuropsychological (NP) functions in a sample of patients with first episode schizophrenia.

  14. Seasonal variation in hippocampal volume in a food-storing bird, the black-capped chickadee

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neurobiology 1995-05-01 Hippocampus size on brain scans

    Black-capped chickadees (Parus atricapillus) in upstate New York show a peak in food-hoarding intensity in October.

  15. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neurovirology 1995-03-01 Caregiving

    Progressive multifocal leukoencephalopathy, a formerly rare disease that chiefly occurred in persons with underlying lymphoma and chronic lymphocytic leukemia, is now seen with increasing frequency in the era of acquired immunodeficiency syndrome.

    Why it matters

    This review is about progressive multifocal leukoencephalopathy, a disease that increased with AIDS, and its diagnosis and therapy. It is not about Alzheimer's disease and does not test any treatment, cure, or prevention for it.

  16. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neuroscience 1995-01-01 Disease mechanisms

    We studied a synatophysin-like immunoreactivity in the hippocampal formation of patients with definite Alzheimer's disease, multi-infarct dementia, patients with no evidence of clinical dementia with neuropathological findings fulfilling the criteria of possible Alzheimer's disease, and age-matched nondemented controls.

  17. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Proceedings of the National Academy of Sciences of the United States of America 1994-08-01 Disease mechanisms

    The stability of proteins that constitute the neurofibrillary tangles and senile plaques of Alzheimer disease suggests that they would be ideal substrates for nonenzymatic glycation, a process that occurs over long times, even at normal levels of glucose, ultimately resulting in the formation of advanced glycation end products (AGEs).

  18. X-ray-induced chromatid damage in cells from Down syndrome and Alzheimer disease patients in relation to DNA repair and cancer proneness

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Cancer genetics and cytogenetics 1993-10-01 Down syndrome and Alzheimer's

    Frequencies of chromatid aberrations in response to G2-phase x-irradiation were compared in PHA-stimulated blood lymphocytes from healthy control subjects, Down syndrome (DS) patients, and Alzheimer disease (AD) patients.

    Why it matters

    This laboratory study found that cells from Down syndrome patients had deficient repair of X-ray-induced DNA damage compared to Alzheimer's disease and control cells. It describes a cellular difference but does not test any treatment, cure, or prevention for Alzheimer's disease.

  19. Spatial learning impairment parallels the magnitude of dorsal hippocampal lesions, but is hardly present following ventral lesions

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The Journal of neuroscience : the official journal of the Society for Neuroscience 1993-09-01 Hippocampus size on brain scans

    The hippocampus plays an essential role in spatial learning.

  20. Functional roles of microglia in the brain

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neuroscience research 1993-08-01 Inflammation and the immune system

    It has been suggested that microglia, a type of glial cells in the central nervous system, play various important roles in normal and pathologic brains.

  21. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. The American journal of psychiatry 1992-07-01 Hippocampus size on brain scans

    This finding is consistent with the notion that schizophrenia involves pathology of and dysfunction within a widely distributed neocortical-limbic neural network that has been implicated in, among other activities, the performance of cognitive tasks requiring working memory.

  22. A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. NMR in biomedicine 1991-04-01 Vascular contributions

    The structure and function of the chemicals contributing to the three main peaks seen with 1H NMR spectroscopy, N-acetyl-L-aspartate (NAA), creatine/phosphocreatine (Cr), and choline-containing compounds (Cho) is reviewed and the changes seen with these compounds in various disease states are briefly outlined.

  23. The consequences of chromosome imbalance

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. American journal of medical genetics. Supplement 1990-01-01 Down syndrome and Alzheimer's

    Review of the clinical cytogenetic literature provides compelling evidence for a specific relationship between imbalance of particular chromosomes or chromosomal regions and the appearance of defined patterns of phenotypic abnormalities.

    Why it matters

    This review of cytogenetic literature states that the regions responsible for many aspects of the Down syndrome phenotype, including Alzheimer's disease, have not been defined, and that loci on many parts of chromosome 21 likely play a role. It reports no treatment, cure, or prevention.

  24. Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Neuroscience letters 1989-08-01 Disease mechanisms

    Alzheimer disease (AD) as well as other dementing disorders are characterized by a continuous loss of neurons in cortical and subcortical areas and probably by an extensive synaptic loss.

  25. A light and electron microscopic study of experimental portal-systemic (ammonia) encephalopathy. Progression and reversal of the disorder

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Laboratory investigation; a journal of technical methods and pathology 1977-06-01 Inflammation and the immune system

    A sequential light and electron microscopic study of cerebral cortex was performed in a rat model of portal-systemic encephalopathy produced by creating a portacaval shunt and followed by ammoniate resin feedings.

From across this topic

10 of the 4,748 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.

Other topics